{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:08:20Z","timestamp":1781197700294,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10787-025-01988-4","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:58:28Z","timestamp":1760003908000},"page":"6931-6941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of cyclosporine in colitis: An updated meta-analysis of randomized control trials (1998 to 2024)"],"prefix":"10.1007","volume":"33","author":[{"given":"Aqsa","family":"Mehreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma Azeem","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6368-2715","authenticated-orcid":false,"given":"Muneeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida Fatima","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"1","key":"1988_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/etm.2012.545","volume":"4","author":"S Bamba","year":"2012","unstructured":"Bamba S, Andoh A, Imaeda H (2012) Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors. Exp Ther Med 4(1):99\u2013104","journal-title":"Exp Ther Med"},{"issue":"5","key":"1988_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/ecco-jcc\/jjaa226","volume":"15","author":"B Barberio","year":"2021","unstructured":"Barberio B, Black CJ, Savarino EV, Ford AC (2021) Ciclosporin or infliximab as rescue therapy in acute glucorticosteroid-refractory ulcerative colitis: systematic review and network meta-analysis. J Crohns Colitis 15(5):733\u2013741","journal-title":"J Crohns Colitis"},{"key":"1988_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00384-012-1602-8","volume":"28","author":"KH Chang","year":"2013","unstructured":"Chang KH, Burke JP, Coffey JC (2013) Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis 28:287\u2013293","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"1988_CR4","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","volume":"94","author":"RD Cohen","year":"1999","unstructured":"Cohen RD, Stein R, Hanauer SB (1999) Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 94(6):1587\u20131592","journal-title":"Am J Gastroenterol"},{"key":"1988_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1053\/gast.2001.23983","volume":"120","author":"G D\u2019Haens","year":"2001","unstructured":"D\u2019Haens G, Geboes K et al (2001) Intravenous cyclosporine versus intravenous glucocorticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120:1323\u20131329","journal-title":"Gastroenterology"},{"key":"1988_CR6","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","volume":"158","author":"JD Feuerstein","year":"2020","unstructured":"Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S (2020) AGA Institute Clinical Guidelines Committee. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology 158:1450\u20131461","journal-title":"Gastroenterology"},{"key":"1988_CR7","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.3390\/jcm12103378","volume":"12","author":"BL Gordon","year":"2023","unstructured":"Gordon BL, Battat R (2023) Therapeutic drug monitoring of infliximab in acute severe ulcerative colitis. J Clin Med 12:3378","journal-title":"J Clin Med"},{"key":"1988_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/BF02234594","volume":"44","author":"GM Hyde","year":"2001","unstructured":"Hyde GM, Jewell DP, Kettlewell MGW, Mortensen NJ (2001) Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum 44:1436\u20131440","journal-title":"Dis Colon Rectum"},{"key":"1988_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","volume":"89","author":"G J\u00e4rnerot","year":"1985","unstructured":"J\u00e4rnerot G, Rolny P, Sandberg-Gertz\u00e9n H (1985) Intensive intravenous treatment of ulcerative colitis. Gastroenterology 89:1005\u20131013","journal-title":"Gastroenterology"},{"key":"1988_CR10","doi-asserted-by":"crossref","unstructured":"Klemm N, Leung Y (2024) Acute severe ulcerative colitis: review of management and emerging treatments. Can IBD Today.","DOI":"10.58931\/cibdt.2024.2229"},{"key":"1988_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","volume":"380","author":"D Laharie","year":"2012","unstructured":"Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier J, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas J, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, F\u00e4rkkil\u00e4 M, Gisbert J, Marteau P, Nahon S, De Vos M, Franchimont D, Mary J, Colombel J, L\u00e9mann M (2012) Ciclosporin versus infl iximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 380:1909\u20131915","journal-title":"Lancet"},{"key":"1988_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.cgh.2020.08.001","volume":"19","author":"D Laharie","year":"2020","unstructured":"Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Beaugerie L, Ricart F, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Buisson A, Coffin B, Roblin X, Assche GV, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, De Vos M, Peyrin-Biroulet L, Mary JY (2020) Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine. Clin Gastroenterol Hepatol 19:1180\u20131188","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1988_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6","journal-title":"Nat Rev Dis Primers"},{"key":"1988_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","author":"L Mcguinness","year":"2020","unstructured":"Mcguinness L, Higgins JPT (2020) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. https:\/\/doi.org\/10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"1988_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cgh.2006.04.001","volume":"4","author":"DN Moskovitz","year":"2006","unstructured":"Moskovitz DN, Van Assche G, Maenhout B (2006) Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 4:760\u2013765","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1988_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/ajg.2016.7","volume":"111","author":"N Narula","year":"2016","unstructured":"Narula N, Marshall JK, Colombel JF, Leontiadis GI, Williams JG, Muqtadir Z, Reinisch W (2016) Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids. Am J Gastroenterol 111(4):477\u2013491","journal-title":"Am J Gastroenterol"},{"key":"1988_CR17","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.3390\/jcm13237446","volume":"13","author":"E Ong Ming San","year":"2024","unstructured":"Ong Ming San E, Sharif K, Rosiou K, Rennie M, Selinger CP (2024) Recent advances in the management of acute severe ulcerative colitis. J Clin Med 13:7446","journal-title":"J Clin Med"},{"key":"1988_CR18","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"1988_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5009\/gnl14226","volume":"9","author":"SC Park","year":"2015","unstructured":"Park SC, Jeen JY (2015) Current and emerging biologics for ulcerative colitis. Gut Liver 9(1):18","journal-title":"Gut Liver"},{"key":"1988_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1463-1318.2012.03188.x","volume":"15","author":"MP Powar","year":"2013","unstructured":"Powar MP, Martin P, Croft AR et al (2013) Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy. Colorectal Dis 15:374\u2013379","journal-title":"Colorectal Dis"},{"key":"1988_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005091","volume":"4","author":"AC Seagrove","year":"2014","unstructured":"Seagrove AC, Alam MF, Alrubaiy L, Cheung WY, Clement C, Cohen D, Grey M, Hilton M, Hutchings H, Morgan J, Rapport F, Roberts S, Russell D, Russell I, Thomas L, Thorne K, Watkins A, Williams J (2014) Randomised controlled trial comparison of iNfliximab and ciclosporin in steroid resistant ulcerative colitis: trial design and protocol (CONSTRUCT). BMJ Open 4:e005091","journal-title":"BMJ Open"},{"issue":"2","key":"1988_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ibd.21680","volume":"18","author":"M Sj\u00f6berg","year":"2012","unstructured":"Sj\u00f6berg M, Walch A, Meshkat M et al (2012) Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis 18(2):212\u2013218","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1988_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1590\/0102-6720201600030017","volume":"29","author":"CW Sobrado","year":"2016","unstructured":"Sobrado CW, Sobrado LF (2016) Management of acute severe ulcerative colitis: a clinical update. Arq Bras Cir Dig 29(3):201\u2013205","journal-title":"Arq Bras Cir Dig"},{"key":"1988_CR24","first-page":"14898","volume":"366","author":"JA Sterne","year":"2019","unstructured":"Sterne JA, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ Open 366:14898","journal-title":"BMJ Open"},{"issue":"4","key":"1988_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0016-5085(03)01214-9","volume":"125","author":"G Van Assche","year":"2003","unstructured":"Van Assche G, Dhaens G, Noman M, Vermeire S, Hiele M, Asnong K, Arts J, Dhoore A, Penninckx F, Rutgeerts P (2003) Randomized, double-blind comparison of 4 mg\/kg versus 2 mg\/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125(4):1025\u20131031","journal-title":"Gastroenterology"},{"issue":"1","key":"1988_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","volume":"1","author":"JG Williams","year":"2016","unstructured":"Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D, Gordon JN, Hawthorne AB, Hilton M, Hutchings HA, Jawhari AU, Longo M, Mansfield J, Morgan J, Rapport F, Seagrove A, Sebastian S, Shaw I, Travis S, Watkins A (2016) Infliximab versus ciclosporin for steroid-resistant acutesevere ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol 1(1):15\u201324","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01988-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:02:59Z","timestamp":1763420579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01988-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01988-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests, financial or non-financial, directly or indirectly related to the work submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable (NA). This study is a meta-analysis of previously published data and does not involve any new human or animal participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable (NA). No new participants were enrolled in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable (NA). No individual data or identifiable information is included in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}